SynthesisJournal of cancer research and clinical oncology2019

A comparison of regorafenib and fruquintinib for metastatic colorectal cancer: a systematic review and network meta-analysis.

Zhu Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.